GSC
SCMP

Ground Swell Capital’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Ground Swell Capital’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1K Buy
+80
New +$531 ﹤0.01% 2286

Other funds holding SCMP

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ground Swell Capital's SCMP Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Sucampo Pharmaceuticals, Inc. (SCMP) in Q3 2014: 80 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2286 among its holdings.

69 funds tracked by Wall St. Rank hold SCMP as of Q3 2014.

  • Ground Swell Capital held 80 shares of Sucampo Pharmaceuticals, Inc. worth $1K as of Q3 2014.
  • Sucampo Pharmaceuticals, Inc. was a new Ground Swell Capital position in Q3 2014.
  • Sucampo Pharmaceuticals, Inc. made up ﹤0.01% of Ground Swell Capital's portfolio in Q3 2014, its #2286 holding.
  • 69 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.